Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

Abstract

UNLABELLED This article summarizes part of a consensus meeting about mycophenolate (MPA) therapeutic drug monitoring held in Rome under the auspices of The Transplantation Society in November 2008 (Clin J Am Soc Nephrol. 2010;5:341-358). This part of the meeting focused on the clinical pharmacokinetics of MPA and included discussion on how to measure MPA… (More)
DOI: 10.1016/j.trre.2010.06.001

Topics

4 Figures and Tables

Cite this paper

@article{Tett2011MycophenolateCP, title={Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.}, author={Susan E. Tett and Franck Saint-Marcoux and Christine Elizabeth Staatz and Merçe Brunet and Alexander A. Vinks and Masatomo Miura and Pierre Marquet and Dirk Kuypers and Teun van Gelder and Dario Cattaneo}, journal={Transplantation reviews}, year={2011}, volume={25 2}, pages={47-57} }